{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:54:30Z","timestamp":1787162070482,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T00:00:00Z","timestamp":1759017600000},"content-version":"am","delay-in-days":301,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.bioorg.2024.107835","type":"journal-article","created":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T11:19:46Z","timestamp":1727090386000},"page":"107835","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Simplified scalable synthesis of a water-soluble toll-like receptor 2 agonistic lipopeptide adjuvant for use with protein-based viral vaccines"],"prefix":"10.1016","volume":"153","author":[{"given":"Deshkanwar S.","family":"Brar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arshpreet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhuri T.","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikazu","family":"Honda-Okubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolai","family":"Petrovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak B.","family":"Salunke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2024.107835_b0005","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.01526","article-title":"Impact of vaccines; health, economic and social perspectives","volume":"11","author":"Rodrigues","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bioorg.2024.107835_b0010","first-page":"153","article-title":"Recombinant subunit vaccines: potentials and constraints","volume":"121","author":"Clark","year":"2005","journal-title":"Dev. Biol. (Basel)"},{"issue":"4","key":"10.1016\/j.bioorg.2024.107835_b0015","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1038\/nm1210","article-title":"Targeting the innate immune response with improved vaccine adjuvants","volume":"11","author":"Pashine","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.bioorg.2024.107835_b0020","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.812774","article-title":"Toll-like receptor signaling and its role in cell-mediated immunity","volume":"13","author":"Duan","year":"2022","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.bioorg.2024.107835_b0025","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1365-2567.2012.03587.x","article-title":"Regulation of B-cell responses by Toll-like receptors","volume":"136","author":"Browne","year":"2012","journal-title":"Immunol."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107835_b0030","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12026-009-8113-x","article-title":"The contribution of direct TLR signaling to T cell responses","volume":"45","author":"Rahman","year":"2009","journal-title":"Immunol. Res."},{"key":"10.1016\/j.bioorg.2024.107835_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2022.102172","article-title":"Toll-like receptor (TLR) agonists as a driving force behind next-generation vaccine adjuvants and cancer therapeutics","volume":"70","author":"Kaur","year":"2022","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107835_b0040","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1021\/acs.jmedchem.0c01627","article-title":"TLR2 agonistic small molecules: detailed structure-activity relationship, applications, and future prospects","volume":"64","author":"Kaur","year":"2021","journal-title":"J. Med. Chem."},{"issue":"18","key":"10.1016\/j.bioorg.2024.107835_b0045","doi-asserted-by":"crossref","first-page":"9587","DOI":"10.1039\/C8RA01387J","article-title":"An efficient and scalable synthesis of potent TLR2 agonistic PAM2CSK4","volume":"8","author":"Kaur","year":"2018","journal-title":"RSC Adv."},{"issue":"7","key":"10.1016\/j.bioorg.2024.107835_b0050","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1021\/jm3000533","article-title":"Structure-activity relationships in human toll-like receptor 2-specific monoacyl lipopeptides","volume":"55","author":"Salunke","year":"2012","journal-title":"J. Med. Chem."},{"issue":"14","key":"10.1016\/j.bioorg.2024.107835_b0055","doi-asserted-by":"crossref","first-page":"5885","DOI":"10.1021\/jm400620g","article-title":"Design and development of stable, water-soluble, human toll-like receptor 2 specific monoacyl lipopeptides as candidate vaccine adjuvants","volume":"56","author":"Salunke","year":"2013","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2024.107835_b0060","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1021\/jm901839g","article-title":"Structure\u2013activity relationships in toll-like receptor-2 agonistic diacylthioglycerol lipopeptides","volume":"53","author":"Wu","year":"2010","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2024.107835_b0065","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1039\/D1MD00372K","article-title":"Stereoisomeric Pam2CS based TLR2 agonists: synthesis, structural modelling and activity as vaccine adjuvants","volume":"13","author":"Kaur","year":"2022","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107835_b0070","article-title":"Hydrophobicity: the door to drug delivery","author":"Falanga","year":"2023","journal-title":"J. Pept. Sci."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107835_b0075","doi-asserted-by":"crossref","first-page":"7030","DOI":"10.1038\/s41598-021-86198-y","article-title":"A smart viral vector for targeted delivery of hydrophobic drugs","volume":"11","author":"Ghosh","year":"2021","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.bioorg.2024.107835_b0080","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4049\/immunohorizons.1700063","article-title":"Recent advances in the discovery and delivery of TLR7\/8 agonists as vaccine adjuvants","volume":"2","author":"Dowling","year":"2018","journal-title":"ImmunoHorizons"},{"key":"10.1016\/j.bioorg.2024.107835_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.05.013","article-title":"Evolution of Toll-like receptor 7\/8 agonist therapeutics and their delivery approaches: from antiviral formulations to vaccine adjuvants","volume":"175","author":"Bhagchandani","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioorg.2024.107835_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121378","article-title":"Combined delivery of TLR2 and TLR7 agonists by nanostructured lipid carriers induces potent vaccine adjuvant activity in mice","volume":"613","author":"Kaur","year":"2022","journal-title":"Int. J. Pharm."},{"issue":"21","key":"10.1016\/j.bioorg.2024.107835_b0095","doi-asserted-by":"crossref","first-page":"8224","DOI":"10.3390\/ijms21218224","article-title":"Pharmaceutical excipients and drug metabolism: a mini-review","volume":"21","author":"Patel","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"15","key":"10.1016\/j.bioorg.2024.107835_b0100","doi-asserted-by":"crossref","first-page":"6873","DOI":"10.1021\/jm500722p","article-title":"N-tetradecylcarbamyl lipopeptides as novel agonists for toll-like receptor 2","volume":"57","author":"Willems","year":"2014","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2024.107835_b0105","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1021\/mp300257x","article-title":"Intranasal administration of the TLR2 agonist Pam2Cys provides rapid protection against influenza in mice","volume":"9","author":"Tan","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bioorg.2024.107835_b0110","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ejmech.2012.02.039","article-title":"Novel glycolipid TLR2 ligands of the type Pam2Cys-\u03b1-Gal: synthesis and biological properties","volume":"51","author":"Thomann","year":"2012","journal-title":"Eur. J. Med. Chem."},{"issue":"17","key":"10.1016\/j.bioorg.2024.107835_b0115","doi-asserted-by":"crossref","first-page":"5846","DOI":"10.1016\/j.bmc.2015.06.070","article-title":"Design, synthesis and immunological evaluation of 1,2,3-triazole-tethered carbohydrate\u2013Pam3Cys conjugates as TLR2 agonists","volume":"23","author":"Nalla","year":"2015","journal-title":"Bioorg. Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2024.107835_b0120","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.immuni.2009.09.018","article-title":"Recognition of lipopeptide patterns by toll-like receptor 2-toll-like receptor 6 heterodimer","volume":"31","author":"Kang","year":"2009","journal-title":"Immunity"},{"issue":"23","key":"10.1016\/j.bioorg.2024.107835_b0125","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1016\/j.vaccine.2022.04.041","article-title":"Covax-19\/Spikogen\u00ae vaccine based on recombinant spike protein extracellular domain with Advax-CpG55.2 adjuvant provides single dose protection against SARS-CoV-2 infection in hamsters","volume":"40","author":"Li","year":"2022","journal-title":"Vaccine"},{"issue":"15","key":"10.1016\/j.bioorg.2024.107835_b0130","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.vaccine.2012.12.077","article-title":"A novel hepatitis B vaccine containing Advax\u2122, a polysaccharide adjuvant derived from delta inulin, induces robust humoral and cellular immunity with minimal reactogenicity in preclinical testing","volume":"31","author":"Saade","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.bioorg.2024.107835_b0135","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semcdb.2020.12.008","article-title":"Aluminium adjuvants in vaccines \u2013 a way to modulate the immune response","volume":"115","author":"Danielsson","year":"2021","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.bioorg.2024.107835_b0140","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41541-018-0089-x","article-title":"Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want","volume":"3","author":"HogenEsch","year":"2018","journal-title":"npj Vaccines"},{"issue":"4","key":"10.1016\/j.bioorg.2024.107835_b0145","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jsps.2011.06.003","article-title":"Vaccine adjuvants - current status and prospects on controlled release adjuvancity","volume":"19","author":"Sivakumar","year":"2011","journal-title":"Saudi Pharm. J."},{"issue":"2","key":"10.1016\/j.bioorg.2024.107835_b0150","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1021\/acsapm.9b01051","article-title":"Temperature-responsive multilayer films of micelle-based composites for controlled release of a third-generation EGFR inhibitor","volume":"2","author":"Xu","year":"2020","journal-title":"ACS Appl. Polym. Mater."},{"issue":"12","key":"10.1016\/j.bioorg.2024.107835_b0155","doi-asserted-by":"crossref","first-page":"14014","DOI":"10.1021\/acsanm.1c03334","article-title":"Temperature-responsive multilayer films based on block copolymer-coated silica nanoparticles for long-term release of favipiravir","volume":"4","author":"Xu","year":"2021","journal-title":"ACS Appl. Nano Mater."},{"issue":"34","key":"10.1016\/j.bioorg.2024.107835_b0160","doi-asserted-by":"crossref","first-page":"30321","DOI":"10.1021\/acsomega.2c03591","article-title":"Steric effects in the deposition mode and drug-delivering efficiency of nanocapsule-based multilayer films","volume":"7","author":"Xu","year":"2022","journal-title":"ACS Omega"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824007405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824007405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T21:23:22Z","timestamp":1738185802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206824007405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":32,"alternative-id":["S0045206824007405"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107835","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Simplified scalable synthesis of a water-soluble toll-like receptor 2 agonistic lipopeptide adjuvant for use with protein-based viral vaccines","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107835","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107835"}}